Note 1 - Nature of Operations, Principles of Consolidation and Basis of Presentation of Interim Financial Statements - Anti-dilutive Option (Details) - shares	3 Months Ended	6 Months Ended
Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Anti-dilutive stock options (in shares)	4,597,283	115,000	4,597,283	115,000
Share-Based Payment Arrangement, Option [Member]
Anti-dilutive stock options (in shares)	4,597,283	115,000	4,597,283	115,000

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration